Company page

Taigen Biopharmaceuticals Holdings Limited

Taigen Biopharmaceuticals Holdings Limited, trading under the ticker 4157, is a public company based in Taiwan. With a market capitalization of approximately 203.8 million USD, the company is engaged in the biopharmaceutical sector. Taigen focuses on developing innovative therapies to address unmet medical needs.